Publications

Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF-Fusion pilocytic astrocytoma

Download PDF
Resource: Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF-Fusion pilocytic astrocytoma

.

Related Articles

CREB5 promotes immunotherapy resistance via tumor-intrinsic collagen matrix deposition

Link
The promise and challenge of spatial omics in dissecting tumour microenvironment and the role of AI

Link